Tumor-educated macrophages promote ferroptosis inhibition in pancreatic cancer via activating the p62-KEAP1-NRF2 pathway
- 1The Affiliated Lianyungang Hospital of Xuzhou Medical University/The First People’s Hospital of Lianyungang, Lianyungang, China
- 2Zhongda Hospital, Southeast University, Nanjing, Jiangsu, China
- 3The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China
Abstract
Background: Pancreatic cancer is one of the most aggressive and lethal gastrointestinal malignancies, and ferroptosis resistance contributes to chemoresistance. Tumor-educated macrophages(TAMs) are key components of the tumor microenvironment, but whether and how they regulate ferroptosis in pancreatic cancer cells remains largely unknown. This study aimed to investigate the regulatory role of tumor-educated macrophages (TEMs) in pancreatic cancer cell ferroptosis and the underlying molecular mechanism.
Methods: TEMs were generated by coculturing THP-1 cells with the pancreatic cancer cell lines PANC1 and CFPAC, and TEM-conditioned medium (TEM-CM) was collected to treat pancreatic cancer cells. Ferroptosis was induced by erastin, and ferroptotic events were assessed by lipid ROS, MDA, iron accumulation, GSH levels, and transmission electron microscopy. RNA sequencing was performed to identify differentially expressed genes. The expression and activity of VEGFR2, C-Raf, ERK1/2, mTOR, LC3, p62, KEAP1, and NRF2 were investigated by treating cells with pharmacological inhibitors (Ki8751, LY3009120, chloroquine, and ferrostatin-1), performing gene knockdown and overexpression, and conducting Western blot co-immunoprecipitation, ubiquitination, and cycloheximide chase assays. In vivo experiments were conducted using an orthotopic mouse model of pancreatic cancer (n = 5 per group).
Results: TEM-CM reduced the sensitivity of PANC1 and CFPAC cells to erastin-induced ferroptosis, as evidenced by decreased lipid ROS, MDA, and iron accumulation and increased GSH levels. Neutralization of VEGF, but not IL-10 or TGFβ, significantly reversed the ferroptosis-inhibiting effect of TEM-CM. RNA sequencing identified TM7SF2 as a key mediator. TEM-CM upregulated TM7SF2 mRNA and protein levels, activated mTOR, and suppressed autophagy, leading to p62 accumulation. Accumulated p62 competitively bound KEAP1, disrupted the KEAP1–NRF2 interaction, inhibited NRF2 ubiquitination and degradation, and promoted NRF2 nuclear translocation, thereby upregulating GPX4, HMOX1, and GCLM. Mechanistically, TEM-derived VEGF bound VEGFR2 and activated the C-Raf/ERK1/2 pathway by upregulating TM7SF2, which in turn promoted mTOR phosphorylation. These effects were reversed by TM7SF2 knockdown, VEGF neutralization, VEGFR2 inhibition, or C-Raf inhibition.
Conclusions: These findings suggest that TEM-derived VEGF promotes ferroptosis resistance in pancreatic cancer cells through the VEGFR2–TM7SF2–C-Raf/ERK1/2–mTOR–autophagy–p62–NRF2 axis. This axis may represent a potential therapeutic target for overcoming ferroptosis resistance in pancreatic cancer. However, our conclusions are mainly based on in vitro cell models, and further validation in additional cell lines, patient-derived organoids, and in vivo models is warranted.
Related
- SIRT5 deficiency exacerbates sepsis acute renal injury by activating ACSL4/FTH1 axis dependent ferroptosis
- “Locking” CDK9 inhibition by activating integrator function in HIV transcription
- Warburg metabolism in tumor-conditioned macrophages promotes metastasis in human pancreatic ductal adenocarcinoma
- Decreased FSP1 expression under chronic hypoxia sensitizes human macrophages towards ferroptosis
- IL1B-high macrophages promote ferroptosis-like lipid peroxidation injury in Crohn's disease intestinal epithelium
BibTeX
@article{li2026tumoreducated,
title = {{Tumor-educated macrophages promote ferroptosis inhibition in pancreatic cancer via activating the p62-KEAP1-NRF2 pathway}},
author = {Shouying Li and Dongxue Qi and Hanyang Yi and Lina Yang and Tonglei Xu and Wenkai Zhou and Weidong Xu and Ziheng Xu and Haodong Tang and Fangliang Xie and Chunfang Zhang and Xuyang Liang},
journal = {Frontiers in Immunology},
year = {2026},
month = oct,
doi = {10.3389/fimmu.2026.1938077},
url = {https://doi.org/10.3389/fimmu.2026.1938077},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Tumor-educated macrophages promote ferroptosis inhibition in pancreatic cancer via activating the p62-KEAP1-NRF2 pathway
AU - Shouying Li
AU - Dongxue Qi
AU - Hanyang Yi
AU - Lina Yang
AU - Tonglei Xu
AU - Wenkai Zhou
AU - Weidong Xu
AU - Ziheng Xu
AU - Haodong Tang
AU - Fangliang Xie
AU - Chunfang Zhang
AU - Xuyang Liang
PY - 2026
DA - 2026/10/12
JO - Frontiers in Immunology
DO - 10.3389/fimmu.2026.1938077
UR - https://doi.org/10.3389/fimmu.2026.1938077
AB - Background: Pancreatic cancer is one of the most aggressive and lethal gastrointestinal malignancies, and ferroptosis resistance contributes to chemoresistance. Tumor-educated macrophages(TAMs) are key components of the tumor microenvironment, but whether and how they regulate ferroptosis in pancreatic cancer cells remains largely unknown. This study aimed to investigate the regulatory role of tumor-educated macrophages (TEMs) in pancreatic cancer cell ferroptosis and the underlying molecular mechanism. Methods: TEMs were generated by coculturing THP-1 cells with the pancreatic cancer cell lines PANC1 and CFPAC, and TEM-conditioned medium (TEM-CM) was collected to treat pancreatic cancer cells. Ferroptosis was induced by erastin, and ferroptotic events were assessed by lipid ROS, MDA, iron accumulation, GSH levels, and transmission electron microscopy. RNA sequencing was performed to identify differentially expressed genes. The expression and activity of VEGFR2, C-Raf, ERK1/2, mTOR, LC3, p62, KEAP1, and NRF2 were investigated by treating cells with pharmacological inhibitors (Ki8751, LY3009120, chloroquine, and ferrostatin-1), performing gene knockdown and overexpression, and conducting Western blot co-immunoprecipitation, ubiquitination, and cycloheximide chase assays. In vivo experiments were conducted using an orthotopic mouse model of pancreatic cancer (n = 5 per group). Results: TEM-CM reduced the sensitivity of PANC1 and CFPAC cells to erastin-induced ferroptosis, as evidenced by decreased lipid ROS, MDA, and iron accumulation and increased GSH levels. Neutralization of VEGF, but not IL-10 or TGFβ, significantly reversed the ferroptosis-inhibiting effect of TEM-CM. RNA sequencing identified TM7SF2 as a key mediator. TEM-CM upregulated TM7SF2 mRNA and protein levels, activated mTOR, and suppressed autophagy, leading to p62 accumulation. Accumulated p62 competitively bound KEAP1, disrupted the KEAP1–NRF2 interaction, inhibited NRF2 ubiquitination and degradation, and promoted NRF2 nuclear translocation, thereby upregulating GPX4, HMOX1, and GCLM. Mechanistically, TEM-derived VEGF bound VEGFR2 and activated the C-Raf/ERK1/2 pathway by upregulating TM7SF2, which in turn promoted mTOR phosphorylation. These effects were reversed by TM7SF2 knockdown, VEGF neutralization, VEGFR2 inhibition, or C-Raf inhibition. Conclusions: These findings suggest that TEM-derived VEGF promotes ferroptosis resistance in pancreatic cancer cells through the VEGFR2–TM7SF2–C-Raf/ERK1/2–mTOR–autophagy–p62–NRF2 axis. This axis may represent a potential therapeutic target for overcoming ferroptosis resistance in pancreatic cancer. However, our conclusions are mainly based on in vitro cell models, and further validation in additional cell lines, patient-derived organoids, and in vivo models is warranted.
SN - 1664-3224
ER -